← Open Payments lookup

CHRISTINA INCLAN: Open Payments

NPI 1336454909 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,269 in 36 payments from 10 companies in 2025. Trend: 2023 $1,481 · 2024 $3,156 · 2025 $1,269

Food & beverage: $1,269
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$541
ABBVIE INC.13$301
Otsuka America Pharmaceutical, Inc.3$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$141
Bausch Health US, LLC2$44
E.R. Squibb & Sons, L.L.C.1$26
Almatica Pharma LLC1$21
Axsome Therapeutics, Inc.1$16
Validus Pharmaceuticals LLC1$15
Lundbeck LLC1$14

Products named: UZEDY, VRAYLAR, CAPLYTA, REXULTI, APLENZIN, ABILIFY ASIMTUFII, COBENFY, LOREEV XR.

Industry payments across TX — which companies pay providers there.